Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 145.31B | 18.2x | -1.3 | CNY 54.38 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.8% Upside | Upgrade to Pro+ | |
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 44.54B | 23.7x | 1.02 | CNY 25.16 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 41.73B | 43.7x | -0.72 | CNY 48.45 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.8% Upside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 30.92B | 19.8x | 0.14 | CNY 68.75 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | |
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 17.33B | -20.2x | -0.95 | CNY 41.54 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 16.36B | -662.8x | -6.8 | CNY 37.35 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 14.62B | -153.3x | 0.8 | CNY 38.33 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beigene | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 12.95B | -0.3x | -1.68 | CNY 187.25 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 12.60B | -5.5x | 0.46 | CNY 28.24 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.9% Upside | Upgrade to Pro+ | |
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 11.39B | -15,580x | CNY 15.49 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.1% Downside | Upgrade to Pro+ | ||
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 11.21B | -28.9x | -1.88 | CNY 11.95 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 7.80B | -21.2x | 17.64 | CNY 13.32 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 7.55B | -20.6x | -0.54 | CNY 18.36 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 7.22B | 54.5x | -1.43 | CNY 59.71 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18% Upside | Upgrade to Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 6.31B | -6.4x | 0.45 | CNY 15.60 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 5.51B | 37.5x | -3.77 | CNY 13.89 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 4.75B | 90.9x | 1.38 | CNY 12.12 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.7% Upside | Upgrade to Pro+ | |
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 4.46B | 31.4x | -9.11 | CNY 47.17 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.7% Upside | Upgrade to Pro+ | |
Bide Pharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 4.28B | 54.2x | -0.91 | CNY 48.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.1% Upside | Upgrade to Pro+ | |
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 4.16B | 34x | 0.99 | CNY 15.24 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.7% Downside | Upgrade to Pro+ | |
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 3.89B | 21.7x | 1.66 | CNY 35.02 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 3.82B | 26.6x | 0.7 | CNY 22.68 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 3.67B | 21x | -1.16 | CNY 34.04 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 3.67B | -9x | 0.54 | CNY 6.64 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.6% Upside | Upgrade to Pro+ | |
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 3.66B | -17.6x | 0.06 | CNY 27.51 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 3.28B | 478.1x | -5.29 | CNY 24.57 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 3.16B | 71.1x | 1.5 | CNY 8.32 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.6% Upside | Upgrade to Pro+ | |
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 3B | 45.8x | -11.65 | CNY 11.84 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CNY 2.97B | -3.2x | 0.07 | CNY 5.98 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CNY 2.90B | -13.6x | -0.4 | CNY 29.18 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |